RxDoctor Payments Data

Stephanie Baker, DO

Family Medicine · Saint Peters, MONPI 1497215891

Payments from drug & device makers

$3,803in general payments, 2019–2025

Across 215 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$419
  • Pfizer$390
  • AbbVie$369
  • Novo Nordisk$348
  • AstraZeneca$322
  • Novartis$270
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$3,803100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,803 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$83,111
Medicare patients
281
Services billed
875

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban78$95,242
OzempicSemaglutide34$47,283
MounjaroTirzepatide38$39,867
XareltoRivaroxaban28$39,711
JardianceEmpagliflozin14$25,378
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$19,730
MyrbetriqMirabegron16$17,204
AbrysvoRsv Vacc, Pref A And Pref B/Pf43$11,556
JanuviaSitagliptin Phosphate11$11,111
ArexvyRsvpref3 Antigen/As01e/Pf23$6,169
Levothyroxine Sodium413$4,879
Atorvastatin Calcium511$4,454
Gabapentin177$3,476
Rosuvastatin Calcium262$2,750
SynthroidLevothyroxine Sodium35$2,703

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo, Paxlovid$390$108,227134 claims
Novo NordiskOzempic$348$47,28334 claims
Lilly USA, LLCMounjaro$419$39,86738 claims
GSKTrelegy Ellipta, Arexvy$260$25,89944 claims
Boehringer IngelheimJardiance$167$25,37814 claims
Astellas Pharma US IncMyrbetriq$46$17,20416 claims
MerckJanuvia$84$11,11111 claims
AbbVieSynthroid$369$2,70335 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Peters

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →